S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

Completed · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combining cytarabine and daunorubicin in treating older patients who have acute myeloid leukemia that has not been previously treated.

Key facts

Study ID
NCT00023777
Run by
SWOG Cancer Research Network
People needed
71
Starts
2001-08-01
Expected to finish
2008-04-01
Last updated by the study team
2015-03-06

Who can join

Age: 56 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.